SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Bio Technology General - BTGC
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Lawrence Burg who wrote (1803)4/14/1999 1:55:00 PM
From: Dave O.  Read Replies (2) of 2028
 
As far as earnings surprises, BTGC came in right on expectations for Q4 (12/98) at 0.10. Q3 they made 0.10, which was a 25% upside surprise if I recall correctly that estimates were only 0.08 that quarter.

For Q1 to be only 0.08 I am surprised a bit. BTGC gives analysts overall guidance and lets the analysts break out their numbers quarter by quarter. I spoke with BTGC a while back asking if there were any major expenses that would hit this quarter that would cause estimates to be lower from Q4 and was told nothing out of the ordinary. And last conference call they indicated that revenues would grow faster than expenses in 1999.

Dave
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News